test

Oshrat Levi

@Sphera Funds Management Ltd.

Latest period2024 - Q3ReportedManaged Assets$628.383MTotal holdings109
Assets growth rate-14.3%Assets growth rate (2-Q avg)-5.64%Continuous growth in asset value0 quarters

Portfolio positions

This chart displays the top 10 holdings in Sphera Funds Management Ltd.'s 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 109 positions.

Assets under management

The assets under management (AUM) of Sphera Funds Management Ltd. over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 628.383M in assets, with a quarterly growth rate of -14.3% and a 2-quarter average growth rate of -5.64%. The portfolio is managed by Oshrat Levi, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
TVTXTravere Therapeutics Inc
Recent Activity
New Position
0.39%
$2.388M↑ Call
170,700 shares@ $13.99 avg price
DYNDyne Therapeutics Inc
Recent Activity
New Position
0.33%
$2.03M
56,504 shares@ $35.93 avg price
VRDNViridian Therapeutics Inc
Recent Activity
New Position
0.32%
$1.959M
86,094 shares@ $22.76 avg price
ALNYAlnylam Pharmaceuticals Inc
Recent Activity
New Position
0.31%
$1.925M
7,000 shares@ $275.03 avg price
CMMBChemomab Therapeutics Ltd
Recent Activity
New Position
0.31%
$1.907M
1.215M shares@ $1.58 avg price
WDAYWorkday Inc
Recent Activity
New Position
0.3%
$1.833M
7,500 shares@ $244.41 avg price
SRRKScholar Rock Hldg Corp
Recent Activity
New Position
0.22%
$1.337M
166,866 shares@ $8.02 avg price
ORICOric Pharmaceuticals Inc
Recent Activity
New Position
0.21%
$1.316M
128,396 shares@ $10.25 avg price
CAPRCapricor Therapeutics Inc
Recent Activity
New Position
0.15%
$938,427
61,698 shares@ $15.22 avg price
TNGXTango Therapeutics Inc
Recent Activity
New Position
0.07%
$385,000
50,000 shares@ $7.7 avg price